Division of Pediatric Cardiology, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA.
The Herma Heart Institute, Children's Wisconsin, 9000 W. Wisconsin Ave, MS 713, Milwaukee, WI, 53226, USA.
Pediatr Cardiol. 2021 Jun;42(5):1119-1125. doi: 10.1007/s00246-021-02589-y. Epub 2021 Apr 7.
The impact of aortic valve replacement (AVR) type on health-related quality of life (HRQOL) in adolescents and young adults is unclear, but may vary depending on need for anticoagulation or re-intervention. We sought to determine the differences in HRQOL following AVR with either the Ross procedure or mechanical AVR in this young population.
Patients 14-35 years old and at least 1 year post-AVR were included. HRQOL was assessed using the Short Form-36 (SF-36). Valve-specific concerns regarding anticoagulation and reoperation were also assessed. Clinical outcome data were obtained by chart review.
A total of 51 patients were enrolled: 24 (47%) Ross and 27 (53%) mechanical AVR. Ross patients were younger at time of AVR (16 vs. 22 years, p < 0.01) and study enrollment (23.7 vs 29.5 years, p < 0.01). Median follow-up from AVR to study enrollment was similar (5.4 years for Ross vs. 5.6 years for mechanical, p = 0.62). At last follow-up, clinical outcomes including cardiac function, functional class, and aortic valve re-intervention rates were similar between groups, although mechanical valve patients had more bleeding events (p = 0.012). SF-36 scores were generally high for the entire cohort, with no significant difference between groups in any domain. Mechanical AVR patients reported more concern about frequency of blood draws (p < 0.01). Concern for reoperation was similar between both groups.
Despite more bleeding events and concern about the frequency of blood draws, adolescents and young adults with mechanical AVR reported similarly high levels of HRQOL compared to those following Ross AVR.
主动脉瓣置换(AVR)类型对青少年和年轻成年人健康相关生活质量(HRQOL)的影响尚不清楚,但可能因抗凝或再次干预的需要而有所不同。我们旨在确定在这一年轻人群中,行 Ross 手术或机械 AVR 后 HRQOL 的差异。
纳入年龄在 14-35 岁且 AVR 后至少 1 年的患者。使用健康调查简表 36 项(SF-36)评估 HRQOL。还评估了抗凝和再次手术的瓣膜特异性顾虑。通过病历回顾获取临床结果数据。
共纳入 51 例患者:24 例(47%)行 Ross 手术,27 例(53%)行机械 AVR。Ross 组患者 AVR 时年龄更小(16 岁比 22 岁,p<0.01)和研究入组时年龄更小(23.7 岁比 29.5 岁,p<0.01)。AVR 到研究入组的中位随访时间相似(Ross 组 5.4 年,机械组 5.6 年,p=0.62)。在最后一次随访时,两组间的临床结局包括心功能、功能分级和主动脉瓣再次干预率相似,尽管机械瓣患者的出血事件更多(p=0.012)。SF-36 评分在整个队列中普遍较高,两组间在任何领域均无显著差异。机械 AVR 患者报告更频繁的抽血(p<0.01)。两组对再次手术的担忧相似。
尽管机械 AVR 患者有更多的出血事件和对抽血频率的担忧,但与 Ross AVR 相比,青少年和年轻成年人的机械 AVR 报告的 HRQOL 水平同样较高。